Outlook Therapeutics, Inc. ($OTLK)
Haddadin Yezan Munther โ Director
Shares
29,000
Price
$0.83
Total Value
$24,145.40
P&L
+22.4% (+$5,414.30)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Haddadin Yezan Munther |
|---|---|
| Title | Director |
| Transaction Date | Jun 2, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 3, 2026 |
| Shares Purchased | 29,000 |
| Price per Share | $0.83 |
| Total Value | $24,145.40 |
| Shares Owned After | 66,167 |
| Derivative | No |
| Accession Number | 0001649989-26-000005 |
| Document | View SEC Filing |